Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.56 – $0.57
100% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3M | $3.7M | $10.1M | $11.7M | $9.3M | $5.4M | $9.4M | $13.2M |
| Cost of revenue | $1.3M | $1.3M | $1.6M | $1.3M | $1.3M | $1.4M | $1.8M | $2.2M |
| Gross profit | $1.0M | $2.4M | $8.5M | $10.4M | $8.0M | $3.9M | $7.6M | $10.9M |
| Gross margin | 44.3% | 65.0% | 84.4% | 88.9% | 85.7% | 73.1% | 80.9% | 83.2% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$1.2M | −$80.7K | $6.5M | $7.5M | $7.0M | $2.6M | −$255.1K | $6.1M |
| EBITDA | $4.4M | $385.8K | $5.6M | $8.1M | $8.7M | $947.9K | −$1.4M | $4.4M |
| Net income | $3.0M | −$11.9M | $2.1M | $5.6M | $14.5M | −$369.5K | −$852.5K | $947.7K |
| Net margin | 131.0% | -322.4% | 21.1% | 47.9% | 155.7% | -6.9% | -9.1% | 7.2% |
| EPS (diluted) | 0.09 | -0.30 | 0.06 | 0.17 | 0.45 | -0.01 | -0.03 | 0.03 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $33M | $-1.32 | $-1.32–$-1.32 | 1 |
| 2027 | $35M | $-0.24 | $-0.24–$-0.24 | 1 |
Forward consensus · source: Financial Modeling Prep
FLOW CAP CORP
No one on the platform currently holds AHFCF.
No tracked institution reports a position in AHFCF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2020-06-09 | 12500-for-1 |
| 2020-06-09 | 1-for-25000reverse |
| 2018-06-11 | 1-for-12reverse |
No one on the platform has traded AHFCF yet.
| +0.00% |
| $306198 |
| — |
| PCMCPublic Company Management Corp. | $0.41 | +0.00% | $14M | — |
| PPHIPositive Physicians Holdings, Inc. | $8.50 | +13.33% | $31M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 1.9× sales vs its 1.5× historical median P/S.
Fair value ≈ $0.44 · price $0.57 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.